Is Clarithromycin a Potential Treatment for Cachexia in People With Lung Cancer?

Summary

This study aims to identify if clarithromycin (CLM) has potential as a widely available and inexpensive treatment for cachexia (the loss of muscle mass) in people with non-small cell lung cancer (NSCLC). Half the participants will receive clarithromycin and half will receive a placebo.

Timeline

Start

2015-04

Primary completion

2015-10

Completion

2015-10

Drugs

Indications